AB-001 |
Pan Caspase Inhibitor (Z-VAD(OMe)-FMK) |
5 mg |
881 |
AB-002 |
Granzyme B Inhibitor (Z-AAD-CMK) |
5 mg |
625 |
AB-003 |
Caspase-3 / CPP32 Inhibitor (Z-DEVD-FMK) |
5 mg |
978 |
AB-004 |
Caspase-8/FLICE. |
3 mg |
689 |
AB-007 |
Caspase-6 Inhibitor (Z-VEID-FMK) |
3 mg |
694 |
AB-008 |
Caspase-2, 3 Inhibitor (Z-VDVAD-FMK) |
3 mg |
790 |
AB-009 |
Caspase-1,4,5 Inhibitor (Z-WEHD-FMK) |
1 mg |
414 |
AB-010 |
Caspase-4,5,9 Inhibitor (Z-LEHD-FMK) |
1 mg |
356 |
AB-011 |
Caspase-1 / ICE Inhibitor 2 (Z-YVAD-FMK) |
3 mg |
603 |
AB-014 |
Biotin-VAD-FMK, Pan-Caspase Inhibitor |
1 mg |
433 |
AB-015 |
BOC-D-FMK |
5 mg |
781 |
AB-021 |
Caspase-13 Inhibitor (Z-LEED-FMK) |
3 mg |
664 |
AB-022 |
Z-AEVD-FMK |
3 mg |
640 |
AB-024 |
Caspase-1/ICE Inhibitor 2 -CHO (Ac-YVAD-CHO) |
5 mg |
356 |
AB-026 |
Caspase-8/FLICE Inhibitor-CHO (Ac-IETD-CHO) |
5 mg |
356 |
AB-027 |
Caspase-6 Inhibitor-CHO (Ac-VEID-CHO) |
5 mg |
356 |
AB-028 |
Caspase Inhibitor Q-VD-OPH |
5 mg |
795 |
AB-045 |
Biotin-A-A-Phep(Oph)2 |
5 mg |
548 |
AB-046 |
MeOSuc-A-A-Phep(OPh)2 |
5 mg |
554 |
AB-047 |
MeOSuc-A-A-P-Phep(Oph)2 |
5 mg |
584 |
AB-050 |
Calpain Inhibitor 1 (Z-LLY-FMK) |
3 mg |
470 |
AB-051 |
Calpain Inhibitor 2 (Mu-F-hF-FMK) |
5 mg |
543 |
AB-052 |
MMP Inhibitor-1 |
5 mg |
420 |
AB-053 |
Beta-Secretase Inhibitor |
3 mg |
824 |
AB-054 |
Gamma-Secretase Inhibitor |
3 mg |
827 |
AB-055 |
SH-5 |
1 mg |
365 |
AB-056 |
SH-6 |
1 mg |
365 |
AB-057 |
Ac-VAD-CHO |
5 mg |
377 |
AC-001 |
Caspase-1 / ICE Fluorogenic Substrate 2 (Ac-YVAD-AFC) |
10 mg |
405 |
AC-003 |
Caspase-3 / CPP32 Fluorogenic Substrate (Ac-DEVD-AFC) |
10 mg |
451 |
AC-004 |
Caspase-8 / FLICE Fluorogenic Substrate (Ac-IETD-AFC) |
5 mg |
327 |
AC-007 |
Caspase-6 Fluorogenic Substrate (Ac-VEID-AFC) |
10 mg |
500 |
AC-008 |
Caspase-2, 3 Fluorogenic Substrate (Ac-VDVAD-AFC) |
5 mg |
404 |
AC-010 |
Caspase-4,5,9 Fluorogenic Substrate (Ac-LEHD-AFC) |
5 mg |
358 |
AC-021 |
Caspase-1 / ICE Fluorogenic Substrate 1 (Ac-VAD-AFC) |
5 mg |
426 |
AC-023 |
Caspase-1/ICE Substrate 2-pNA (Ac-YVAD-pNA) |
25 mg |
557 |
AC-024 |
Caspase-3/CPP32 Substrate-pNA (Ac-DEVD-pNA) |
25 mg |
440 |
AC-025 |
Caspase-8 Substrate-pNA (Ac-IETD-pNA) |
25 mg |
473 |
AC-026 |
Caspase-6 Substrate-pNA (Ac-VEID-pNA) |
25 mg |
493 |
AC-027 |
Caspase-2,3 Substrate -pNA (Ac-VDVAD-pNA) |
25 mg |
506 |
AC-028 |
Caspase-4,5,9 Substrate -pNA (Ac-LEHD-pNA) |
25 mg |
545 |
AC-029 |
Caspase-1,4,5 Substrate -pNA (Ac-WEHD-pNA) |
25 mg |
594 |
AC-030 |
Granzyme B Substrate 2-pNA (Ac-IEPD-pNA) |
25 mg |
593 |
AC-051 |
MMP Substrate-1 |
5 mg |
459 |
AC-052 |
MMP Substrate-2 |
3 mg |
542 |
AC-053 |
MMP Substrate-3 |
3 mg |
563 |
AC-054 |
MMP Substrate-4 |
3 mg |
563 |
AC-055 |
MMP Substrate-5 |
3 mg |
563 |
AC-056 |
MMP Substrate-6 |
3 mg |
563 |
AC-057 |
Alpha-Secretase Substrate-1 |
1 mg |
437 |
AC-058 |
Alpha-Secretase Substrate-2 |
1 mg |
437 |
AC-059 |
Beta-Secretase Substrate-1 |
1 mg |
447 |
AC-060 |
Beta-Secretase Substrate-2 |
1 mg |
437 |
AC-062 |
Gamma-Secretase Substrate-2 |
1 mg |
438 |
AC-063 |
Granzyme B Fluorogenic Substrate (Ac-IEDP-AFC) |
10 mg |
619 |
AC-064 |
Caspase-1/ICE Substrate pNA (Ac-VAD-pNA) |
25 mg |
552 |
AD-003 |
Caspase-3 / CPP32 Inhibitor / Biotin Tag (Biotin-DEVD-FMK) |
1 mg |
463 |
AD-012 |
Caspase Inhibitor Negative Control / Biotin Tag (Cathepsin B Inhibitor /
Biotin Tag) (Biotin-FA-FMK) |
5 mg |
514 |
AE-001 |
Caspase Inhibitor Negative Control (Cathepsin B Inhibitor) (Z-FA-FMK) |
5 mg |
350 |
AF-016 |
Fas Ligand [CD95 Ligand] Inhibitor |
50 ΅g |
496 |
AP-002 |
Staurosporine |
1 mg |
403 |
AP-004 |
Calphostin C |
1 mg |
461 |
AP-005 |
Swinholide A |
10 ΅g |
293 |
AP-006 |
Fostriecin |
10 ΅g |
293 |
BC-006 |
Beta-Amyloid (1-40) |
1 mg |
508 |
BC-007 |
Beta-Amyloid (1-42) |
1 mg |
964 |
BC-008 |
EDG-1 Blocking Peptide |
50 ug |
297 |
BC-009 |
EDG-1 Control |
100 uL |
297 |
BC-010 |
EDG-2 Blocking Peptide |
50 ug |
297 |
BC-011 |
EDG-2 Control |
100 uL |
297 |
BC-012 |
EDG-4 Control |
100 uL |
297 |
BC-013 |
EDG-6 Blocking Peptide |
50 ug |
297 |
BC-014 |
EDG-6 Control |
100 uL |
297 |
BC-015 |
EDG-7 Blocking Peptide |
50 ug |
297 |
BC-016 |
EDG-7 Control |
100 uL |
297 |
BC-017 |
EDG-8 Blocking Peptide |
50 ug |
297 |
BC-022 |
Orexin-A Peptide |
0.5 mg |
584 |
BC-023 |
Orexin B Peptide, Human |
1 mg |
426 |
BC-024 |
Orexin-B Peptide, Mouse |
1 mg |
426 |
BC-025 |
CART Peptide (55-102), Rat |
100 ug |
408 |
BC-026 |
CART Peptide (55-102), Human |
100 ug |
408 |
BC-027 |
CD40L, human recombinant |
50 ug |
783 |
BC-028 |
AMPA |
10 mg |
377 |
BC-029 |
AMOA |
5 mg |
412 |
BC-030 |
THA |
10 g |
412 |
BC-031 |
JC-1, Iodide |
5 mg |
341 |
BC-032 |
PARP-1, human recombinant |
20 ug |
482 |
BC-033 |
PARP-2, mouse recombinant |
20 ug |
506 |
BC-034 |
DAF-2 DA |
1 mg |
496 |
BC-035 |
DAF-FM DA |
1 mg |
654 |
BC-039 |
DAR-4M AM (Cell Permeable) |
1 mg |
695 |
BC-041 |
[Boc-Glu(ObzL)]2-Lys-Ome |
5 mg |
215 |
BC-042 |
Brain-Derived Neurotrophic Factor, human recombinant |
10 ug |
473 |
BC-043 |
Glial Derived Neurotrophic Factor, Human recombinant |
10 ug |
473 |
BC-044 |
Leptin, murine recombinant |
1 mg |
473 |
BC-045 |
NT-3 (Neurotrophin 3), human recombinant |
10 ug |
473 |
BC-046 |
NT-4 (Neurotrophin 4), human recombinant |
10 ug |
473 |
BC-047 |
Oncostatin M, human recombinant |
10 ug |
473 |
BC-048 |
Osteocalcin, purified bovine |
100 ug |
508 |
BC-050 |
Stem Cell Factor, human recombinant |
10 ug |
473 |
BC-051 |
Stem Cell Factor, murine recombinant |
10 ug |
473 |
BC-052 |
[Boc-Asp(Obzl)-Lys(z)-OtBu], Reversin 121 |
5 mg |
305 |
BC-058 |
MMP-9, Gelatinase B |
10 ug |
777 |
BC-070 |
Hypericin |
10 mg |
748 |
BC-071 |
Pseudohypericin |
10 mg |
878 |
BC-082 |
TWEAK |
10 ug |
502 |
BC-088 |
Sophoricoside, IL-5 Inhibitor |
10 mg |
321 |
BC-089 |
JS-2190, P-GP Inhibitor |
5 mg |
315 |
BC-090 |
PGP-4008, P-GP Inhibitor |
2 mg |
280 |
BC-091 |
TRAIL-His tag, soluble (human recombinant) |
20 ug |
566 |
BC-093 |
Bid, human recombinant |
20 ug |
370 |
BC-094 |
MMP2/9 Inhibitor |
25 mg |
334 |
BC-097 |
APRIL, soluble human recombinant |
30 ug |
613 |
BC-099 |
BMP-2 (>98%), human recombinant |
10 ug |
297 |
BC-113 |
C75 |
5 mg |
378 |
BC-114 |
ACRP30 headless, human |
10 ug |
379 |
BC-115 |
Cerulenin |
50 mg |
566 |
BC-116 |
Caspase-1, human recombinant, active |
25 U |
369 |
BC-117 |
Caspase-1, human recombinant, active |
100 U |
525 |
BC-118 |
Caspase-2, human recombinant, active |
25 U |
344 |
BC-119 |
Caspase-2, human recombinant, active |
100 U |
509 |
BC-120 |
Caspase-4, human recombinant, active |
25 U |
344 |
BC-121 |
Caspase-4, human recombinant active |
100 U |
509 |
BC-122 |
Caspase-5, human recombinant, active |
25 U |
344 |
BC-123 |
Caspase-5, human recombinant, active |
100 U |
509 |
BC-124 |
Caspase-9, human recombinant, active |
25 U |
369 |
BC-125 |
Caspase-9, human recombinant |
100 U |
485 |
BC-126 |
Granzyme A, human recombinant |
10 ug |
438 |
BC-127 |
Granzyme K, human recombinant |
10 ug |
438 |
BC-128 |
ACRP30, mouse recombinant |
50 ug |
467 |
BC-134 |
sRANKL, mouse |
10 ug |
297 |
BC-144 |
Epitope/Affinity Tag Positive Control |
0.2 mL |
303 |
BC-151 |
Histone Protein |
10 ug |
309 |
BC-152 |
Hela Nuclear Extract |
1 mg |
473 |
BC-153 |
Adiponectin, human, recombinant |
25 ug |
414 |
BC-154 |
Adiponectin, mouse, recombinant |
25 ug |
414 |
BC-155 |
Adiponectin, rat, recombinant |
25 ug |
414 |
BC-165 |
BMP-11 |
20 ug |
659 |
BC-232 |
CTGF, C-terminus, human recombinant |
20 ug |
297 |
BC-234 |
Osteoblast Specific Factor 1 (OSF-1) human recomb. |
100 ug |
697 |
BC-235 |
Osteoblast Specific Factor 2 (OSF-2) |
100 ug |
697 |
BC-236 |
BMPR-1A |
100 ug |
612 |
BC-237 |
JNK Inhibitor 1 (L-Stereoisomer) |
200 ul |
365 |
BC-239 |
gAcrp30/Adipolean, human |
25 ug |
297 |
BC-251 |
Leptin, human recomb. |
1 mg |
334 |
BC-255 |
Chetomin |
1 mg |
329 |
BC-257 |
EB-47.2HCl.2H2O |
5 mg |
324 |
BC-258 |
BNP, human recombinant |
10 ug |
414 |
BC-259 |
Flt3-L, human recombinant |
10 ug |
414 |
BC-260 |
Flt3-L, mouse recombinant |
10 ug |
414 |
BC-261 |
Growth Hormone (GH), Ovine recombinant |
100 ug |
637 |
BC-262 |
Growth Hormone (GH), rat recombinant |
100 ug |
508 |
BC-263 |
IGF-I, human recombinant |
100 ug |
414 |
BC-264 |
IGF-I, mouse recombinant |
50 ug |
414 |
BC-265 |
IGF-I, rat recombinant |
50 ug |
414 |
BC-266 |
IGF-II, human recombinant |
50 ug |
414 |
BC-267 |
IGFBP-1, human recombinant |
20 ug |
414 |
BC-269 |
IGFBP-3, human recombinant |
25 ug |
414 |
BC-270 |
IL-1alpha, human recombinant |
10 ug |
414 |
BC-271 |
IL-1 beta, human recombinant |
10 ug |
414 |
BC-272 |
IL-2 beta, mouse recombinant |
10 ug |
414 |
BC-273 |
IL-1Ra, human recombinant |
50 ug |
777 |
BC-274 |
IL-2, human recombinant |
50 ug |
414 |
BC-275 |
IL-3, human recombinant |
10 ug |
414 |
BC-276 |
IL-4, human recombinant |
10 ug |
414 |
BC-277 |
IL-4 mouse recombinant |
10 ug |
414 |
BC-278 |
IL-5, human recombinant |
10 ug |
414 |
BC-279 |
IL-6, human recombinant |
20 ug |
414 |
BC-280 |
IL-6, mouse recombinant |
10 ug |
414 |
BC-281 |
IL-7, human recombinant |
10 ug |
414 |
BC-282 |
IL-9, human recombinant |
10 ug |
414 |
BC-283 |
IL-10, human recombinant |
10 ug |
414 |
BC-284 |
IL-11, human recombinant |
10 ug |
414 |
BC-285 |
IL-15, human recombinant |
10 ug |
414 |
BC-286 |
IL-15, mouse recombinant |
10 ug |
414 |
BC-287 |
IL-15, rat recombinant |
10 ug |
414 |
BC-290 |
IL-20, human recombinant |
10 ug |
414 |
BC-291 |
IL-22, human recombinant |
10 ug |
414 |
BC-292 |
Stem Cell Factor (SCF), human recombinant |
10 ug |
414 |
BC-293 |
Stem Cell Factor (SCF) mouse recombinant |
10 ug |
414 |
BC-294 |
Stem Cell Factor (SCF) rat recombinant |
10 ug |
414 |
BC-295 |
VEGF, human recombinant |
10 ug |
414 |
BC-297 |
VEGF, mouse recombinant |
10 ug |
414 |
BC-298 |
MIP-1alpha, human recombinant |
20 ug |
414 |
BC-299 |
MIP-1 alpha, mouse recombinant |
10 ug |
414 |
BC-300 |
MIP-1beta, human recombinant |
10 ug |
414 |
BC-302 |
MIP-3 beta, human recombinant |
20 ug |
414 |
BC-303 |
MIP-4, human recombinant |
10 ug |
414 |
BC-304 |
Insulin, human recombinant |
250 mg |
566 |
BC-305 |
VEGF121, human recombinant |
10 ug |
414 |
BC-306 |
Thapsigargin |
1 mg |
338 |
BC-307 |
MIA |
20 ug |
420 |
BC-308 |
YC-1 |
25 mg |
379 |
BC-309 |
COMP: Angiopoietin-1 |
10 ug |
496 |
BC-311 |
Visfatin, soluble, human recombinant, His |
50 ug |
537 |
BC-312 |
Visfatin, soluble, mouse recombinant, His |
50 ug |
537 |
BC-313 |
Aristoforin |
1 mg |
334 |
BC-314 |
DICA |
25 mg |
313 |
BC-315 |
Fn14(mouse):Fc |
50 ug |
496 |
BC-316 |
Apotosis Activator 2 |
25 mg |
324 |
BC-317 |
Fn14(mouse):Fc-FITC |
50 ug |
520 |
BC-318 |
Carboxy-PTIO |
50 mg |
305 |
BC-319 |
Fn14(human):Fc |
50 ug |
496 |
BC-320 |
PARP-3 human recombinant |
20 ug |
506 |
BC-321 |
BAFF (human recombinant soluble) |
10 ug |
502 |
BC-322 |
BAFF(mouse recombinant soluble) |
10 ug |
502 |
BC-323 |
BAFF-R(human):Fc(human) |
50 ug |
502 |
BC-324 |
BAFF-R(mouse):Fc(human) recombinant |
50 ug |
502 |
BC-325 |
Go 6976 |
0.5 mg |
303 |
BC-326 |
PR3 Antigen |
1 mg |
5.423 |
BC-327 |
BES-H2O2 |
1 mg |
654 |
BC-328 |
PQ401 |
5 mg |
305 |
BC-329 |
Omentin 1, human recombinant |
10 ug |
426 |
BC-330 |
Nesfatin-1, mouse recombinant |
50 ug |
449 |
BC-331 |
ETB |
200 ug |
678 |
BC-332 |
Reveromycin A Sodium Salt |
500 ug |
584 |
BC-333 |
RKTS-33 |
200 ug |
678 |
BC-334 |
Tryprostatin A |
500 ug |
584 |
BC-335 |
MI-22 |
200 mg |
818 |
BC-336 |
sRANKL, human recombinant |
20 ug |
514 |
BC-337 |
rLaminin-5, human recombinant |
2 ug |
585 |
BC-338 |
rMMP-7, human recombinant |
0.1 mg |
531 |
BC-339 |
rPro-MMP-7, human recombinant |
0.1 mg |
531 |
BMP-C |
Insoluble Bone Collagen |
200 mg |
555 |
BP-002 |
Osteoprotegerin (rhOPG:Fc) |
50 ug |
473 |
BP-010 |
Osteocalcin, Bovine |
100 ug |
403 |
BP-011 |
Osteocalcin, Human |
20 ug |
953 |
BP-012 |
Osteonectin, Bovine |
50 ug |
444 |
BP-013 |
Osteonectin, Humen |
50 ug |
607 |
BP-016 |
BMP-7 (human recombinant) |
10 ug |
414 |
BP-018 |
RANK:Fc |
50 ug |
496 |
BP-019 |
BMP-4, human recombinant |
10 ug |
368 |
BP-020 |
BMP-6, human recombinant |
10 ug |
368 |
BP-021 |
BMP-7, human recombinant |
10 ug |
368 |
BP-022 |
BMP-7 CHO, human recombinant |
10 ug |
414 |
BP-023 |
ProBMP-2, human recombinant |
10 ug |
414 |
BP-024 |
GDF5, human recombinant |
50 ug |
414 |
BP-025 |
AITRL (Osteostat), human recombinant |
20 ug |
414 |
BP-026 |
BMP Receptor Type IA |
10 ug |
414 |
BP-027 |
Elcatonin |
1 mg |
414 |
BP-028 |
Eptifabatide, human |
25 mg |
414 |
CR-001 |
CrmA |
100 ΅g |
438 |
EM-002 |
D-erythro-MAPP |
15 mg |
1.128 |
EN-002 |
Caspase-6, human recombinant |
5 ΅g |
373 |
EN-003 |
Caspase-8 |
5 ΅g |
373 |
EN-004 |
Caspase-3 |
5 ΅g |
373 |
EN-005 |
Caspase-7 |
5 ΅g |
373 |
EN-006 |
Granzyme A, human, natural |
10 ug |
490 |
EN-007 |
Granzyme B, human, natural |
10 ug |
634 |
EN-008 |
Perforin, human, natural |
1 ug |
604 |
FL-101 |
Fas Ligand Protein, soluble |
10 ΅g |
342 |
FL-102 |
Fas, Recombinant Intracellular Fragment |
100 ΅g |
537 |
FL-103 |
Fas Ligand, Soluble Human (no enhancer required) |
5 ug |
387 |
FL-104 |
sFas Ligand Enhancer |
1 x 50 ug |
337 |
GT-101 |
D609 |
50 mg |
461 |
KT-375 |
Herbimycin A |
1 mg |
379 |
LC-519 |
Lactacystin |
1 mg |
461 |
LP-01 |
Carazostatin |
5 mg |
426 |
LP-02 |
Pyrrolostatin |
5 mg |
426 |
MT-100 |
Okadaic Acid (Free Acid) |
100 ΅g |
308 |
MT-400 |
Pyrenacyl Okadaate |
10 ug |
265 |
MT-750 |
Wortmannin |
10 mg |
309 |
MT-800 |
Bafilomycin A1 |
100 ΅g |
338 |
MT-801 |
Folimycin |
100 ΅g |
338 |
MT-803 |
Folimycin (Concanamycin A) |
25 ug |
235 |
MT-804 |
Bafilomycin A1 |
1 mg |
1.467 |
NC-001 |
NCO-700 |
10 mg |
403 |
NC-101 |
NC-1300-B |
10 mg |
403 |
RK-397 |
RK-397 |
5 mg |
403 |
TN-001 |
TNF-alpha, Soluble (mouse recombinant) |
50 ΅g |
414 |
TN-002 |
TNF-alpha, soluble (human recombinant) |
50 ΅g |
414 |
TN-003 |
TNF-R1(human) |
50 ΅g |
496 |
TN-004 |
TNF-R2 (human) |
50 ΅g |
496 |
TR-001 |
TRAIL-FLAG tag, soluble (human recombinant) |
10 ΅g |
342 |
TR-004 |
TRAIL-R1, Human Recombinant Protein |
50 ΅g |
485 |
TR-005 |
TRAIL-R2, Human Recombinant Protein |
50 ΅g |
485 |
TR-006 |
TRAIL-R2, Human Recombinant Protein (FITC labeled) |
50 ΅g |
531 |
TR-007 |
TRAIL-R3, Human Recombinant Protein |
50 ΅g |
485 |
TR-008 |
TRAIL-R4,Human Recombinant Protein |
50 ΅g |
485 |